Abbott Vascular

TriMed Staff | March 24, 2009 | Cardiovascular Business | Patient Care


Abbott's Voyager NC balloon dilation catheter

Abbott Vascular (Booth 2761) is introducing its Xience V everolimus-eluting coronary stent system and its Voyager NC balloon dilation catheter for the treatment of coronary artery disease (CAD). The Xience V, the latest DES to become FDA-approved, releases everolimus, which has been shown to help prevent restenosis.

The Voyager NC is Abbott's next-generation balloon dilatation catheter for the treatment of CAD. The device was designed to restore blood flow in both pre-dilatation and post-dilatation procedures, and is available in several balloon diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm). The Voyager NC is available on a rapid exchange delivery system.

TriMed Staff

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business

Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Related Content

Around the web